Difference between revisions of "DBP2:Main"
From NAMIC Wiki
Line 10: | Line 10: | ||
| | | | ||
{| | {| | ||
− | | colspan="2" width="100px" align="left" valign="top" | [[Image:ProstateDiagram.png | + | | colspan="2" width="100px" align="left" valign="top" | [[Image:ProstateDiagram.png|200px|]] |
| width="250pt" valign="top" | Gabor Fichtinger, Jonathan Fiene, Christopher W. Kennedy, Gernot Kronreif, Iulian I. Iordachita, Danny Y. Song, E. Clif Burdette, and Peter Kazanzides. | | width="250pt" valign="top" | Gabor Fichtinger, Jonathan Fiene, Christopher W. Kennedy, Gernot Kronreif, Iulian I. Iordachita, Danny Y. Song, E. Clif Burdette, and Peter Kazanzides. |
Revision as of 16:29, 19 December 2007
Home < DBP2:MainBack to NA-MIC Cores
|
DBP 2 Overview
The NA-MIC Driving Biological Problems (DBP) Core 3.2 identifies key biological problems to drive NA-MIC projects from 2007 to 2010. From the beginning of the NCBC project, NIH planned for a three year cycle for the DBPs. In accordance with this policy, in 2007 the DBPs were shifted from schizophrenia to lupus, autism, velocardiofacial syndrome (VCSF), and prostate cancer. The process of selecting these DBPs is detailed here.
DBP 2 Projects - Organized by Site
DBP 2 Projects - Organized by Subject Matter
Meetings and Events
Cross-links to meetings and events specifically related to these DBPs.